Century Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Net Income	-21.94	-126.57	-136.67	-130.93	-95.82	-53.58	Upgrade
Depreciation & Amortization	13.3	13.3	13.04	8.44	3.75	1.4	Upgrade
Other Amortization	-	-	0.09	0.3	0.31	0.09	Upgrade
Asset Writedown & Restructuring Costs	4.33	4.33	16.37	-	-	4.72	Upgrade
Loss (Gain) From Sale of Investments	-4.55	-4.81	-3.98	-	-	-	Upgrade
Stock-Based Compensation	11.91	12.69	14.62	10.67	4.73	0.88	Upgrade
Other Operating Activities	-1.1	0.2	-1.2	1.63	0.83	0.35	Upgrade
Change in Accounts Payable	-1.8	-1.47	-2.36	-4.79	-1.85	2.06	Upgrade
Change in Unearned Revenue	-114.9	-6.59	-2.24	117.99	-	-	Upgrade
Change in Other Net Operating Assets	0.25	-1.22	13.98	10.75	-0.95	2.8	Upgrade
Operating Cash Flow	-114.51	-110.14	-88.35	14.05	-89	-41.27	Upgrade
Capital Expenditures	-0.09	-0.15	-13.74	-30.6	-44.97	-9.83	Upgrade
Cash Acquisitions	-9.61	-9.61	-	-	-	-4.72	Upgrade
Investment in Securities	73.57	57.24	74.87	17.48	-253.37	-8.21	Upgrade
Investing Cash Flow	63.87	47.48	61.13	-13.13	-298.34	-22.76	Upgrade
Long-Term Debt Issued	-	-	-	-	-	9.73	Upgrade
Long-Term Debt Repaid	-	-	-10.24	-	-	-	Upgrade
Net Debt Issued (Repaid)	-	-	-10.24	-	-	9.73	Upgrade
Issuance of Common Stock	74.32	74.56	0.52	27.16	277.07	38.1	Upgrade
Other Financing Activities	-17.83	-	-	-	-18.92	-0.14	Upgrade
Financing Cash Flow	56.49	74.56	-9.73	27.16	417.77	47.69	Upgrade
Net Cash Flow	5.85	11.91	-36.94	28.08	30.43	-16.34	Upgrade
Free Cash Flow	-114.6	-110.29	-102.08	-16.55	-133.97	-51.09	Upgrade
Free Cash Flow Margin	-99.74%	-1673.84%	-4567.52%	-318.37%	-	-	Upgrade
Free Cash Flow Per Share	-1.35	-1.40	-1.72	-0.29	-4.14	-6.83	Upgrade
Cash Interest Paid	-	-	0.59	1.1	0.97	0.21	Upgrade
Cash Income Tax Paid	0.5	0.5	2.52	-	0.01	-	Upgrade
Levered Free Cash Flow	5.62	49.44	-71.09	-79.59	-96.45	-30.01	Upgrade
Unlevered Free Cash Flow	5.62	49.44	-70.85	-79	-95.96	-29.87	Upgrade
Change in Net Working Capital	0.94	-108.08	6.54	-9.89	0.1	-8.42	Upgrade

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q